Papers and Presentations
How to use Search
You can use search for sourcing a variety of content on the CASSS website. CASSS makes available any content with author approval.
Refine Results
Filter By Content Type
Filter By Resource Type
Filter By Event Types
- WCBP (97)
- Higher Order Structure (85)
- CMC Strategy Forum (78)
- AT Europe (72)
- Cell & Gene Therapy Products (65)
- Mass Spectrometry (50)
- CMC Strategy Forum Europe (48)
- CMC Strategy Forum North America Winter (40)
- CE Pharm (39)
- CMC Strategy Forum Japan (33)
- Bioassays (21)
- CMC Strategy Forum North America Summer (15)
- CMC Strategy Forum China (14)
- CMC Strategy Forum North America Fall (13)
- CMC Strategy Forum Latin America (9)
- Biophysics Working Group (8)
- NorCal Regional Forum (6)
- Midwest Regional Forum (2)
- Netherlands Area Biotech Discussion Group (1)
- DC Area Scientific Discussion Group (1)
Filter By Tags
-
3D Structure of Biologics in a Convenient Immunoassay Format
Speaker Presentation Wang Xing Array Bridge 2017
-
Challenges with Equivalence Testing According to USP
Speaker Presentation Stegmann Ralf Stegmann Systems 2017
-
Bioassays in Product Development: An Immuno-Oncology Perspective
Speaker Presentation Stauffer Tara Bristol-Myers Squibb 2017
-
Setting up Acceptance Criteria with the Application of Equivalence Test and Geometric Mean Following USP Chapters -A Cell-based Potency Assay Case Study
Speaker Presentation Shi Liming Pfizer 2017
-
Comparative Analytical Method Transfer - Setting Acceptance Criteria
Speaker Presentation Rugaiganisa Andrew Pfizer 2017
-
Development of Generic Goal Posts for Equivalence Testing of Potency Assay Methods
Speaker Presentation Pflanzner Thorsten AbbVie 2017
-
Bioassay Method Transfer: Regulator’s Perspective and Case Studies
Speaker Presentation Nemec Martin Health Canada 2017
-
Antibody-Mediated Effector
Function: Learning and
Challenges from Early
Discovery to Development
Speaker Presentation Mehta Payal Eli Lilly & Company 2017
-
Expectations for Bioassays - An Assessor's View
Speaker Presentation Jost Nils Paul Ehrlich Institut 2017
-
Biological Activity Testing - Regulatory Considerations
Speaker Presentation Bower Hoefnagel Marcel Medicines Evaluation Board 2017
-
Automation Friendly Assay Design
Speaker Presentation Bower Hepler Christopher Catalent 2017
-
Tier 1 Biosimilarity Assessments – A Practical Illustration
Speaker Presentation Bower Keith University of Washington 2017
-
Use of Echo® Liquid Handlers to Improve the Efficiency and Reliability of Bioassay Laboratories
Speaker Presentation Allison Tim Labcyte 2017
-
Phase-Specific Control Strategy Considerations for Cell and Gene Therapy Products – a Canadian Perspective
Speaker Presentation Storbeck Christopher Health Canada 2020
-
Label-free Single Cell Analysis to Monitor Cell Development and Surveil Quality of ATMP Products
Speaker Presentation Schütze Karin CellTool 2020
-
Management of Manufacturing Changes and
Comparability of Cellular and Gene Therapy
Products
Speaker Presentation Salz Tal US FDA 2020
-
A Risk-Based Approach to the Implementation of a Control Strategy for Advanced Therapy Medicinal Products
Speaker Presentation Pillsbury Darius ValSource 2020
-
Challenges with Cell Based Medicines in the EU
Speaker Presentation Menezes Ferreira Margarida 2020
-
CMC Challenges During Accelerated Development of Human Cell & Gene Therapy Products - A CBER Perspective
Speaker Presentation Kwilas Anna US FDA 2020
-
Usage of an mRNA Platform Technology for “Light Speed” Development of a Vaccine Against SARS-CoV-2
Speaker Presentation Kuhn Andreas Biontech 2020
View On Demand Content
To view the content, visit https://casss.digitellinc.com, login to your account, and select the meeting from the list of past events. Visit the On Demand Presentations and Speaker Slides tab to view available content.
For 2021 meetings, content will be available for one year after the program. For 2022 and beyond, content will be available for three months.